Subhdeep Virk, MD
Psychiatry · Buffalo, NYNPI 1225195381
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,725 of the $3,763 with a category attached, or 72.4%. Johnson & Johnson accounts for 67.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $2,525 and has fallen 87.3% since, to $322 in 2025.
Across 12 payments — averaging $313.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Janssen Research & Development, LLC$917
- Janssen Scientific Affairs, LLC$200
- Lilly USA, LLC$122
Across 504 payments — averaging $5945.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$1.5M
- AbbVie$549K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$443K
- Boehringer Ingelheim$232K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$174K
- Boehringer Ingelheim International GmbH$81K
- plus $60K from 3 others
What the payments were for
- Consulting fees$2,72572%
- Travel & lodging$63917%
- Food & beverage$40011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $2,525 |
| Janssen Research & Development, LLC | 9 | $917 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Lilly USA, LLC | 1 | $122 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,763 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Buffalo
- Wendy WeinsteinBuffalo$388K
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.